The Alzheimer's Association offers continuing medical education on Alzheimer's and dementia, including free CE options. These resources help physicians, radiologists, neurologists, nurses, advanced practice nurses, physician assistants, psychiatrists, social workers, pharmacists and other clinicians to remain current in this fast-changing field.

Conferences offering CME on Alzheimer's and dementia

Alzheimer's Association International Conference® (AAIC®)

Alzheimer's Association International Conference (AAIC)The Alzheimer's Association International Conference (AAIC) is the largest and most influential international meeting dedicated to advancing dementia science. Each year, AAIC convenes the world’s leading basic science and clinical researchers, next-generation investigators, clinicians and the care research community to share research discoveries that will lead to methods of prevention and treatment and improvements in the diagnosis of Alzheimer’s disease. AAIC 2025 will take place in Toronto and online, July 27-31, 2025.

Continuing education credits are jointly provided by Postgraduate Institute for Medicine (PIM) and the Alzheimer’s Association.

CE credits from AAIC 2024 expire on Sept. 1, 2025. Continuing education information for AAIC 2025 will be available later this year.

Credits: AAIC 2024 offers a maximum of 26.75 continuing education credits.
Expiration: Sept. 1, 2025

Audience: Biochemists, geriatric psychiatrists, geriatric specialists, molecular and cell biologists, neurologists, neuroscientists, nurses, pharmacologists, primary care physicians, psychiatrists, psychologists, radiologists and social workers.

Learn More

Webinars and other free online CME opportunities

An Introduction to Amyloid-Related Imaging Abnormalities (ARIA) and Its Management

Continuing Medical Education Catalog

See all available continuing education and register.

See the Full Catalog
With the Food and Drug Administration’s approval of a first-in-class anti-amyloid therapeutic, the management of amyloid-related imaging abnormalities, or ARIA will move into clinical practice. Clinicians and radiologists are required to assess and mitigate ARIA risk, identify ARIA in its multiple presentations and manage ARIA. This CME course will explain the phenomenon of ARIA, along with its epidemiology, presentation, prognosis and management. Attendees will also review case studies.

Upon completing this session you will be able to:
 
  • Differentiate between ARIA-e and ARIA-H.
  • Recognize risk factors and understand what determines the evolution and course of ARIA.
  • Implement recommendations for appropriate clinical management of ARIA.
Credits: 1 hour AMA PRA Category 1 Credit™
Expiration: July 1, 2026
Audience: All medical professionals, especially physicians, nurse practitioners, physician assistants, neurologists, psychiatrists, psychologists and radiologists.

Learn More

 

ALZ-NET International Case Study Series: Exploring Eligibility Episode 1​

This webinar series uses a case study approach to explore issues surrounding the eligibility of patients being evaluated for treatment with novel FDA-approved Alzheimer’s therapies and discusses appropriate treatment protocols. 

Learning objectives:

  • Discuss patient treatment eligibility criteria for novel FDA-approved Alzheimer’s therapies.
  • Understand treatment considerations for novel FDA-approved Alzheimer’s therapies.
  • Discuss clinical questions that may arise at treatment sites.

Credits: 1 hour AMA PRA Category 1 Credit™
Expiration: May 2026
Audience: Primary care clinicians including internists, family physicians, radiologists, neurologists, nurse practitioners and pharmacists who are seeking additional education in the assessment, diagnosis, treatment and ongoing health care of patients with cognitive impairment and dementia.

Learn More

 

Dementia Clinical Care Education Series

This four-part continuing education video series outlines strategies for dementia care including: epidemiology, diagnosis, assessment and mild cognitive impairment. Concluding with case presentations for real-world application.

Credits: .5 hour AMA PRA Category 1 Credit™ per module (4 modules total)
Expiration: Oct. 19, 2025
Audience: Primary care clinicians including internists, family physicians, radiologists, neurologists, nurse practitioners and physician assistants who are seeking additional education in the assessment, diagnosis and ongoing health care of patients with cognitive impairment and dementia.

Learn More

 

Modifiable Risk Factors for Dementia Microlearning Series

This four-part microlearning video series will address the topic of modifiable risk factors, lifestyle and behaviors that can reduce or increase a person’s chances of developing dementia. This series will outline evidence-based risk reduction interventions for dementia focused on:

  1. Physical activity.
  2. Diabetes/obesity.
  3. Vascular risks.
  4. Tobacco use.

Credits: .25 hour AMA PRA Category 1 Credit™ per module (4 modules total)
Expiration: Oct. 10, 2025
Audience: Primary care clinicians including internists, family physicians, radiologists, neurologists, nurse practitioners and physician assistants who are seeking additional education in the assessment, diagnosis and ongoing health care of patients with cognitive impairment and dementia.

Learn More

 

The Alzheimer's and Dementia Care ECHO® Program

The Alzheimer's and Dementia Care ECHO Program is a free, case-based telementoring program that uses videoconferencing technology to connect dementia experts with primary care teams to spread best-practice guidance for dementia detection, diagnosis and management. Participants have the ability to earn up to 12 free CME/CNE/CEUs through participation in the live sessions.

Credits: 1 hour/session, up to 12 hours
Audience: Primary care clinicians and their care teams.

Learn More
 

See the current Alzheimer's and dementia courses and webinars in the Continuing Medical Education Catalog.

 

Other professional development

These events, webinars and trainings will be of interest to medical professionals, care professionals and the Alzheimer's research community.
 

Questions? Contact clinicaledu@alz.org